Reducing Hereditary Cancer Act has not moved since its introduction on Jul 23, 2025, with cosponsors from both parties
IntroducedJul 23, 2025
Reported—
Passed one chamber—
Passed both—
Law—
What it changes · CRS summary
Written by the Congressional Research Service [2]. 45 words.
Reducing Hereditary Cancer Act This bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings.
Context
- Committees
- House Energy and Commerce Committee
House Ways and Means Committee - Policy area
- Health: 122 of 9,357 bills became law, 113th–118th (1.3%)
- Sponsor
- 2 of 106 bills enacted since 2013
- Text versions
- 1: introduced in house · 706 words
- Latest action
- Jul 23, 2025: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Records
- Congress.gov · Bill text
Exhibit 1Passage odds band at each stage, rated when the bill reached it [4]
Related bills · 1
Each bill appears once, under its strongest link. 1 in all.
Related, per CRS or House · 1
- 119th S. 2760 Reducing Hereditary Cancer Act of 2025 R · Introduced
Exhibit 2Articles naming the bill per day, last 90 days, US sources [3]